Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer

This study is currently recruiting participants.
Verified February 2014 by Odense University Hospital
Sponsor:
Information provided by (Responsible Party):
Mark Ellebaek Pedersen, Odense University Hospital
ClinicalTrials.gov Identifier:
NCT01706809
First received: October 11, 2012
Last updated: February 4, 2014
Last verified: February 2014

October 11, 2012
February 4, 2014
September 2011
September 2015   (final data collection date for primary outcome measure)
The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival. [ Time Frame: after the study is complete ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01706809 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer
Not Provided

The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.

Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative and after 3 month peripheral blood samples is collected.

A total of 50 patients will be included in this study.

The study is approved by the local scientific ethical committee No. S-20100006

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Patients undergoing open LAR for rectum cancer is subjected.

Rectal Cancer
Other: blood sampels from vena rectalis superior and vena cubiti
Biomarkeres
Intervention: Other: blood sampels from vena rectalis superior and vena cubiti
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
December 2015
September 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Histological verified cancer
  • The cancer must be located in rectum maximum of 15 cm.
  • Age above 18

Exclusion Criteria:

  • Disseminated cancer
  • Perioperative radio-chemotherapy
  • Laparoscopy surgery
Both
18 Years and older
No
Not Provided
Denmark
 
NCT01706809
S-20100006, S-20100006
No
Mark Ellebaek Pedersen, Odense University Hospital
Odense University Hospital
Not Provided
Not Provided
Odense University Hospital
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP